HAEMATOLOGIST AND DISEASE GROUP LEAD: MYELOMA AT T
Haematology
The Peter MacCallum Cancer Centre
Australia
A/Prof Simon Harrison is the lead Haematologist for Myeloma at the VCCC and Peter MacCallum Cancer Centre, Director of Clinical Apheresis, and a clinician scientist in the Sir Peter MacCallum department of Oncology in Melbourne University. Clinical research His clinical research is focused in the field of multiple myeloma examining novel therapies including novel drug combinations, early phase clinical trial design and the incorporation of novel biomarkers into clinical protocols and cellular therapy. Laboratory research A/ Prof Harrison work focuses on the immunopathology of multiple myeloma, the impact of novel drug combinations and immune therapies. He is also collaborating on the development of POL1 inhibitors in combination with other novel drugs to target ribosome biogenesis.
HAEMATOLOGY; MYELOMA; CELL THERAPY; CLINICAL TRIAL DEVELOPMENT